Azurity Pharmaceuticals Acquires Sebela's Bowel Prep Franchise
November 17, 2025
Azurity Pharmaceuticals has acquired Sebela Pharmaceuticals' bowel preparation franchise, including two leading bowel prep therapies used for colonoscopies. The deal transfers Sebela's commercial team (more than 50 colleagues) and is intended to strengthen Azurity's gastroenterology product portfolio and U.S. market presence.
- Buyers
- Azurity Pharmaceuticals
- Targets
- Sebela Pharmaceuticals' Bowel Prep Franchise
- Sellers
- Sebela Pharmaceuticals
- Industry
- Pharmaceuticals
- Location
- Massachusetts, United States
- Transaction Type
- Divestiture
Explore More
Build a buyer list for your deal
Find active buyers from recent acquisition patterns and move straight into outreach.